Temasek bags $793m from latest Celltrion sale
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Asia

Temasek bags $793m from latest Celltrion sale

medical waste

Temasek Holdings pocketed W902bn ($793m) from its second sell-down in South Korea’s Celltrion this year, after pricing it at the investor-friendly end of the range.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article